Marrone Bio Innovations Inc (NASDAQ:MBII) traded up 22.9% during trading on Friday . The stock traded as high as $1.96 and last traded at $1.77. 533,870 shares traded hands during mid-day trading, an increase of 383% from the average session volume of 110,461 shares. The stock had previously closed at $1.44.
Several equities research analysts have commented on the company. ValuEngine upgraded Marrone Bio Innovations from a “strong sell” rating to a “sell” rating in a research note on Friday, February 2nd. Zacks Investment Research cut Marrone Bio Innovations from a “hold” rating to a “sell” rating in a research note on Thursday, February 15th. Finally, HC Wainwright set a $4.00 target price on Marrone Bio Innovations and gave the company a “buy” rating in a research note on Thursday, December 21st. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. Marrone Bio Innovations has a consensus rating of “Hold” and a consensus target price of $2.50.
The company has a debt-to-equity ratio of -1.14, a quick ratio of 0.36 and a current ratio of 0.69.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3255015/marrone-bio-innovations-mbii-trading-22-9-higher.html.
Marrone Bio Innovations Company Profile
Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.
Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.